Advisor Consultant Network’s Gilead Sciences GILD Stock Holding History

Advisor Consultant Network’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$638K	Buy	+8,060	New	+$655K	0.09%	132

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Advisor Consultant Network's GILD Position: Q3 2016 in Review

Advisor Consultant Network opened a new position in Gilead Sciences (GILD) in Q3 2016: 8,060 shares worth $638K. The stake represents 0.09% of the portfolio and ranks #132 among its holdings.

1,561 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Advisor Consultant Network held 8,060 shares of Gilead Sciences worth $638K as of Q3 2016.
Gilead Sciences was a new Advisor Consultant Network position in Q3 2016.
Gilead Sciences made up 0.09% of Advisor Consultant Network's portfolio in Q3 2016, its #132 holding.
1,561 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Advisor Consultant Network's 13F filing for Q3 2016, filed 14 Oct 2016.